Form4insider filings, from the source

SEC Form 4 · accession 0001103780-15-000053

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Bunka
Officer — CEO · Director · 10% Owner
Period of report
Jan 20, 2010
Accepted (ET)
Oct 16, 2015 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common SharesOct 15, 2015P3,000$0.185A5,821,196D
Common SharesOct 15, 2015P21,200$0.1834A5,842,396D
Common SharesOct 15, 2015P5,000$0.1825A5,847,396D
Common SharesOct 15, 2015P11,000$0.18A5,858,396D
Common SharesOct 15, 2015P2,000$0.1835A5,860,396D
Common SharesOct 15, 2015P5,000$0.184A5,865,396D
Common SharesOct 15, 2015P300$0.183A5,865,696D
Common SharesOct 16, 2015P6,500$0.19A5,872,196D
Common SharesOct 16, 2015P20,000$0.185A5,892,196D
Common SharesOct 16, 2015P5,000$0.1849A5,897,196D
Common SharesOct 16, 2015P2,500$0.20A5,899,696D
Common Sharesholding———4,488,958IPrivate holding company
Common Sharesholding———5,818,196D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options$0.11holding———Dec 23, 2014Dec 23, 2019Common Shares500,000500,000D
Stock Options$0.35holding———Jul 11, 2011Jul 11, 2016Common Shares200,000700,000D
Stock Options$0.10holding———Jun 18, 2013Jun 18, 2018Common Shares225,000925,000D
Warrants$0.25holding———May 15, 2015May 15, 2017Common Shares170,000170,000I